The patients with PTCH1 mutations had a higher ratio of lung, liver, or distant lymph node metastasis (Table 5) and worse recurrence-free survival (Figs 2 and 6B). This evidence concerns the gene PTCH1 and metastatic malignant neoplasm in the lymph nodes.